Methodology

Determination of the most appropriate method for extrapolating overall survival data from a placebo-controlled clinical trial of lenvatinib for progressive, radioiodine-refractory differentiated thyroid cancer

Tremblay G, Livings C, Crowe L, Kapetanakis V, Briggs A

ClinicoEconomics and Outcomes Research 2016, 8:323-333

Published Date: 30 June 2016